Related Experiment Video
Updated: Aug 5, 2026

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
A Case Report and a Review of TRAPPC4-Related TRAPPopathy
Anil Kumar1, Ajay Kumar1, Arvinder Wander2
1Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, India.
Summary
Neurodevelopmental disorder with spasticity, epilepsy and brain atrophy (NEDESBA) is a rare genetic condition linked to TRAPPC4 gene mutations. Early molecular testing is crucial for diagnosing NEDESBA, which can mimic metabolic disorders.
Area of Science:
- Genetics
- Neuroscience
- Rare Diseases
Background:
- Neurodevelopmental disorder with spasticity, epilepsy and brain atrophy (NEDESBA) is a rare autosomal recessive condition.
- It is associated with pathogenic variants in the TRAPPC4 gene, part of the TRAPP complex crucial for cellular functions.
- TRAPPopathies present overlapping clinical features like microcephaly, epilepsy, and intellectual disability.
Purpose of the Study:
- To report a case of NEDESBA in a 13-month-old male with unique symptoms.
- To highlight the diagnostic challenges due to phenotypic overlap with metabolic disorders.
- To emphasize the importance of early molecular genetic testing.
Main Methods:
- Clinical case presentation of a pediatric patient.
- Biochemical screening for metabolic disorders (biotinidase deficiency).
- Whole exome sequencing to identify the genetic variant.
Main Results:
- The patient presented with epileptic spasms, neurodevelopmental delay, hair loss, and skin rashes.
- Initial metabolic screening suggested biotinidase deficiency, but it was ruled out.
- Whole exome sequencing identified a homozygous splice-site variant (c.454+3A>G) in the TRAPPC4 gene, confirming NEDESBA.
Conclusions:
- The case highlights the phenotypic variability and overlap of NEDESBA with metabolic disorders.
- Early molecular testing is essential for accurate diagnosis of NEDESBA.
- TRAPPC4 variants are a significant cause of rare neurodevelopmental disorders, particularly in consanguineous populations.
